arrow
D

David Cibula

Department of Obstetrics and Gynecology
H指数:73
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cervical cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆

宫颈癌:ESMO临床实践指南——诊断、治疗与随访<a class="anchor anchor-primary" href="#fn1" name="bfn1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="fn1"><span class="anchor-text-container"><span class="anchor-text"><sup>☆</sup></span></span></a>

2026-09-240
OAAI
High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavage

高级别浆液性卵巢癌与子宫灌洗液中TP53突变负荷增加相关

2026-08-290
OA
Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research

第一届妇科肿瘤学组宫颈癌共识会议的临床研究共识声明

2026-07-270
PRE
Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy

聚腺苷二磷酸核糖聚合酶抑制剂尼拉帕利维持治疗接受多斯塔利姆单抗联合化疗的原发进展或复发性子宫内膜癌患者

2026-06-060
PRE
Prospective comparison of diagnostic accuracy of ultrasound, PET/CT and DW-MRI for preoperative assessment of pelvic lymph nodes in cervical cancer patients: results of the CANNES trial

前瞻性比较超声、PET/CT和DW-MRI在宫颈癌患者术前评估盆腔淋巴结诊断准确性的研究:CANNES试验结果

2026-05-240
OA
Pelvic exenteration for vulvar cancer: contemporary outcomes from a multinational cohort study

外阴癌的盆腔廓清术:跨国队列研究的当代结局

2026-02-190
OAAI
COmplications and REcurrence after Pelvic EXenteration for gynecologic malignancies: analysis of surgical complications from the COREPEX study.

盆腔廓清术后妇科恶性肿瘤的并发症与复发:COREPEX研究中手术并发症的分析。

2025-11-250
OAAI
Comparison of ultrasound with computed tomography and whole-body diffusion-weighted MRI in prediction of surgical outcome using ESMO-ESGO criteria in patients with tubo-ovarian carcinoma: prospective ISAAC study

比较超声与计算机断层扫描和全身扩散加权MRI在预测输卵管卵巢癌患者手术结局中的应用:前瞻性ISAAC研究(采用ESMO-ESGO标准)

2025-11-040
OAAI
European Society of Gynaecological Oncology (ESGO) Resource-Stratified Guidelines for the management of patients with cervical cancer

欧洲妇科肿瘤学会(ESGO)基于资源水平的宫颈癌患者管理指南

2025-10-170
PRE
Sentinel lymph node mapping in early-stage cervical cancer: Results from the SENTIX prospective multicenter study

早期宫颈癌的哨兵淋巴结显像:SENTIX前瞻性多中心研究的结果

2025-10-090
PRE
A randomized, phase III study of sacituzumab govitecan versus treatment of physician’s choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)

一项关于sacituzumab govitecan与医生选择治疗方案在经过铂类化疗和免疫治疗后的子宫内膜癌患者中的随机、III期研究:ASCENT-GYN-01研究(GOG-3104/ENGOT-en26/APGOT-EN2)。

2025-09-070
PRE
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025

ESGO–ESTRO–ESP关于子宫内膜癌患者管理的指南:2025年更新

2025-07-280
PRE
Sentinel lymph node biopsy without systematic pelvic lymphadenectomy in females with early-stage cervical cancer: final outcome of the SENTIX prospective, single-arm, noninferiority, international trial

早期宫颈癌女性患者前哨淋巴结活检而不进行系统性盆腔淋巴结清扫术: SENTIX前瞻性单臂非劣效性国际试验的最终结果

2025-07-040
PRE
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trial

在无胚系BRCA1和/或BRCA2突变且对铂类敏感的复发性卵巢癌患者中应用奥拉帕尼单药维持治疗:OPINION试验的最终总生存结果

2025-06-010
OAAI
Decoding the Molecular Landscape of 262 Uterine Sarcomas: RNA-Seq Clustering of Endometrial Stromal Sarcomas, Uterine Tumors Resembling Ovarian Sex Cord Tumors, and Undifferentiated Uterine Sarcomas With Prognostic Insights

解码262例子宫肉瘤的分子景观:具有预后见解的子宫内膜间质肉瘤、卵巢性索样子宫肿瘤和未分化子宫肉瘤的RNA-Seq聚类分析

2025-05-240
PRE